Ultraviolet radiation drives mutations in a subset of mucosal melanomas.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 01 2021
Historique:
received: 10 07 2020
accepted: 25 11 2020
entrez: 12 1 2021
pubmed: 13 1 2021
medline: 22 1 2021
Statut: epublish

Résumé

Although identified as the key environmental driver of common cutaneous melanoma, the role of ultraviolet radiation (UVR)-induced DNA damage in mucosal melanoma is poorly defined. We analyze 10 mucosal melanomas of conjunctival origin by whole genome sequencing and our data shows a predominance of UVR-associated single base substitution signature 7 (SBS7) in the majority of the samples. Our data shows mucosal melanomas with SBS7 dominance have similar genomic patterns to cutaneous melanomas and therefore this subset should not be excluded from treatments currently used for common cutaneous melanoma.

Identifiants

pubmed: 33431815
doi: 10.1038/s41467-020-20432-5
pii: 10.1038/s41467-020-20432-5
pmc: PMC7801393
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

259

Subventions

Organisme : Cancer Research UK
ID : A27412
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A22902
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100282/Z/12/Z
Pays : United Kingdom

Références

Melanoma Manag. 2018 Oct 08;5(3):MMT11
pubmed: 30459941
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Mod Pathol. 2017 Feb;30(2):286-296
pubmed: 27739435
J Hum Genet. 2016 Apr;61(4):361-2
pubmed: 26657935
N Engl J Med. 2017 Nov 9;377(19):1824-1835
pubmed: 28891423
APMIS. 2016 Jun;124(6):475-86
pubmed: 27004972
J Pathol. 2013 Jul;230(3):261-9
pubmed: 23620124
N Engl J Med. 2018 May 10;378(19):1789-1801
pubmed: 29658430
Cancer Res. 2004 May 15;64(10):3414-27
pubmed: 15150093
J Oncol. 2018 Dec 2;2018:1908065
pubmed: 30631354
Nat Methods. 2018 Aug;15(8):591-594
pubmed: 30013048
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Clin Cancer Res. 2019 Jun 15;25(12):3548-3560
pubmed: 30782616
Bioinformatics. 2012 Sep 15;28(18):i333-i339
pubmed: 22962449
Ann Oncol. 2015 Jan;26(1):64-70
pubmed: 25319062
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Cancer Cell. 2017 Aug 14;32(2):204-220.e15
pubmed: 28810145
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Nat Commun. 2019 Jul 18;10(1):3163
pubmed: 31320640
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Med. 2019 Feb;25(2):221-224
pubmed: 30510256
Clin Cancer Res. 2013 Jun 15;19(12):3143-52
pubmed: 23633454
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):270-5
pubmed: 20018764
Annu Rev Pathol. 2014;9:239-71
pubmed: 24460190
JAMA Ophthalmol. 2018 Nov 1;136(11):1236-1241
pubmed: 30352118
BMC Cancer. 2016 Aug 12;16:634
pubmed: 27520988
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Curr Opin Oncol. 2010 May;22(3):178-83
pubmed: 20401974
N Engl J Med. 2015 Jun 25;372(26):2521-32
pubmed: 25891173
Eur J Cancer. 2019 Sep;119:168-178
pubmed: 31445199
JAMA Ophthalmol. 2017 Dec 1;135(12):1434-1437
pubmed: 29121185
Genome Biol. 2016 Feb 22;17:31
pubmed: 26899170
Oncotarget. 2019 Jan 29;10(9):930-941
pubmed: 30847022
Oncotarget. 2017 Jun 20;8(25):40683-40692
pubmed: 28380455
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
Nat Commun. 2020 May 15;11(1):2408
pubmed: 32415113

Auteurs

Piyushkumar A Mundra (PA)

Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, SK10 4TG, UK.

Nathalie Dhomen (N)

Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, SK10 4TG, UK.

Manuel Rodrigues (M)

Institut Curie, PSL Research University, INSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe labellisée par la Ligue Nationale contre le Cancer, 75248, Paris, France.
Institut Curie, PSL Research University, Department of Medical Oncology, 75248, Paris, France.

Lauge Hjorth Mikkelsen (LH)

Department of Pathology/Eye Pathology Section, University of Copenhagen, Rigshospitalet, 2100, Copenhagen, Denmark.

Nathalie Cassoux (N)

Institut Curie, PSL Research University, Department of Ocular Oncology, 75248, Paris, France.

Kelly Brooks (K)

Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, SK10 4TG, UK.
QIMR Berghofer Medical Research Institute, Brisbane, Queensland, 4006, Australia.

Sara Valpione (S)

Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, SK10 4TG, UK.
The Christie NHS Foundation Trust, Manchester, M20 4GJ, UK.

Jorge S Reis-Filho (JS)

Experimental Pathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.

Steffen Heegaard (S)

Department of Pathology/Eye Pathology Section, University of Copenhagen, Rigshospitalet, 2100, Copenhagen, Denmark.

Marc-Henri Stern (MH)

Institut Curie, PSL Research University, INSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe labellisée par la Ligue Nationale contre le Cancer, 75248, Paris, France.
Institut Curie, PSL Research University, Department of Genetics, 75248, Paris, France.

Sergio Roman-Roman (S)

Institut Curie, PSL Research University, Translational Research Department, 75248, Paris, France.

Richard Marais (R)

Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, SK10 4TG, UK. richard.marais@cruk.manchester.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH